Table 1 Patient demographics

Age (years) (median/min/max)

55.5/32.0/72.0

Mean weight ± SD (kg) (range)

73.1 ± 14.6 (50-108)

Median months from diagnosis of metastatic disease to study entry (months) (range)

14.4 (1.6-67.2)

WHO performance status (n = 26)

   0

17

   1

9

Steroid hormone receptor status (n = 24)

   ER and/or PR⁺

18

   ER and PR^-

8

HER2 status ^a (n = 22)

   HER2⁺

5

   HER2^-

17

Metastatic tumor sites (n = 26)

   Lung

17

   Bone

15

   Liver

13

   Lymph nodes

12

   Lesions on more than one organ

22

Race (n = 26)

   Caucasian

20

   Asian

2

   Hispanic

1

   African-American

3